ALTR » Topics » RESEARCH AND DEVELOPMENT EXPENSE

This excerpt taken from the ALTR 10-Q filed Apr 27, 2009.

Research and Development Expense

Research and development expense includes costs for compensation and benefits, stock-based compensation expense, development masks, prototype wafers, and depreciation and amortization. These expenditures are for the design of new PLD and ASIC families, the development of process technologies, new package technology, software to support new products and design environments, and IP cores.

We will continue to make significant investments in the development of new products and focus our efforts on the development of new programmable logic devices that use advanced semiconductor wafer fabrication processes, as well as related development software. We are currently investing in the development of future silicon products, as well as our Quartus ® II software, our library of IP cores, and other future products.

 

     Three Months Ended     Year-
Over-Year
Change
    Sequential
Change
 

($ in millions)

   March 27,
2009
    March 28,
2008
    December 31,
2008
     

Research and Development Expense

   $ 58.2     $ 61.1     $ 68.8     -5 %   -15 %

Percentage of Net Sales

     22.0 %     18.2 %     21.9 %    

Research and development expense for the three months ended March 27, 2009 decreased by $2.9 million, or 5%, when compared to the three months ended March 28, 2008. The decrease was primarily due to a gain of $3.6 million from the substantive termination of our retiree medical plan and a $3.8 million decrease in variable compensation expense based on lower 2009 operating results. These decreases were partially offset by a $3.5 million increase in spending on masks and wafers and a $1.3 million increase in stock-based compensation expense. See Note 13 – Employee Benefit Plans to our condensed consolidated financial statements for a detailed discussion of the substantive termination of our retiree medical plan.

 

21


Table of Contents
These excerpts taken from the ALTR 10-K filed Feb 25, 2009.

RESEARCH AND DEVELOPMENT EXPENSE

Research and development expense includes costs for compensation and benefits, stock-based compensation, development masks, prototype wafers, and depreciation and amortization. These expenditures are for the design of new PLD and ASIC families, the development of process technologies, new package technology, software to support new products and design environments, and IP cores.

We will continue to make significant investments in the development of new products and focus our efforts on the development of new programmable logic devices that utilize advanced semiconductor wafer fabrication processes, as well as related development software. We are currently investing in the development of future silicon products, as well as our Quartus II software, our library of IP cores, and other future products.

 

($ in millions)    2008    2007    2006   

2008 vs.

2007 Change

  

2007 vs.

2006 Change

Research and Development Expense

   $ 257.7    $ 261.8    $ 246.1    -2%    6%
 

Percentage of Net Sales

     19%      21%      19%      

Research and development expense decreased $4.1 million in 2008 compared to 2007. This decrease was attributable to lower spending in 2008 on new product development masks of $21.4 million due mainly to the product launch of the

 

34


Table of Contents

Stratix III and Cyclone III device families in 2007. The decrease in spending on development masks was partially offset by an increase in compensation and benefits of $11.9 million due to variable compensation expense associated with 2008 operating results and an increase in stock-based compensation expense of $2.5 million.

Research and development expense increased $15.7 million in 2007 compared to 2006 primarily due to increased labor costs and increased spending on development masks and prototype wafers, partially offset by a decrease in stock-based compensation expense. Spending on development masks and prototype wafers increased by $14.4 million in 2007 due to new product launches. Stock-based compensation expense decreased by $8.2 million to $20.4 million in 2007 compared to 2006. During the fourth quarter of 2007, we recorded a $1.7 million restructuring charge, of which $1.0 million was related to employee severance costs.

RESEARCH AND DEVELOPMENT EXPENSE

STYLE="margin-top:6px;margin-bottom:0px; margin-left:3%">Research and development expense includes costs for compensation and benefits, stock-based compensation, development masks, prototype wafers, and
depreciation and amortization. These expenditures are for the design of new PLD and ASIC families, the development of process technologies, new package technology, software to support new products and design environments, and IP cores.


We will continue to make significant investments in the development of new products and focus our efforts on the development of new programmable logic
devices that utilize advanced semiconductor wafer fabrication processes, as well as related development software. We are currently investing in the development of future silicon products, as well as our Quartus II software, our library of IP cores,
and other future products.

 




































































($ in millions)  2008  2007  2006  

2008 vs.

ALIGN="right">2007 Change

  

2007 vs.

ALIGN="right">2006 Change

Research and Development Expense

  $257.7  $261.8  $246.1  -2%  6%
 

Percentage of Net Sales

   19%   21%   19%    

Research and development expense decreased $4.1 million in 2008 compared to 2007. This
decrease was attributable to lower spending in 2008 on new product development masks of $21.4 million due mainly to the product launch of the

 


34







Table of Contents



Stratix III and Cyclone III device families in 2007. The decrease in spending on development masks was partially offset by an increase in compensation and
benefits of $11.9 million due to variable compensation expense associated with 2008 operating results and an increase in stock-based compensation expense of $2.5 million.

FACE="Times New Roman" SIZE="2">Research and development expense increased $15.7 million in 2007 compared to 2006 primarily due to increased labor costs and increased spending on development masks and prototype wafers, partially offset by a
decrease in stock-based compensation expense. Spending on development masks and prototype wafers increased by $14.4 million in 2007 due to new product launches. Stock-based compensation expense decreased by $8.2 million to $20.4 million in 2007
compared to 2006. During the fourth quarter of 2007, we recorded a $1.7 million restructuring charge, of which $1.0 million was related to employee severance costs.

FACE="Times New Roman" SIZE="2">SELLING, GENERAL, AND ADMINISTRATIVE EXPENSE

Selling, general, and administrative expense
primarily includes labor and benefit expenses related to sales, marketing, and administrative personnel, stock-based compensation for those personnel, commissions and incentives, depreciation, legal, advertising, facilities, and travel expenses.

 




































































($ in millions)  2008  2007  2006  2008 vs.
2007 Change
  2007 vs.
2006 Change

Selling, General and
Administrative Expense

  $255.4  $272.1  $304.6  -6%  -11%
 

Percentage of Net Sales

   19%   22%   24%    

Selling, general, and administrative expense decreased by $16.7 million in 2008 compared to
2007. The decrease was attributable to our continued efforts to increase efficiency and reduce cost in legal and consulting services, stock-based compensation, compensation and benefits, and other areas. Consulting costs decreased by $6.3 million
due primarily to the absence in 2008 of costs incurred in 2007 related to implementation of our enterprise resource planning system. Stock-based compensation decreased by $4.2 million in 2008 compared to 2007. Compensation and benefits expenses
decreased by $2.0 million in 2008 compared to 2007. The decrease in compensation and benefits is the net result of a decrease of $9.4 million, resulting from our cost-reduction efforts described above, substantially offset by an increase of $7.4
million in variable compensation expense associated with 2008 operating results. The absence in 2008 of $3.5 million of restructuring charges recognized in 2007 (discussed below) was substantially offset by a $2.6 million increase in non-recurring
charges related to the elimination of certain external sales representatives and employee termination costs.

Selling, general, and
administrative expense
decreased by $32.5 million in 2007 compared to 2006. The decrease was primarily due to efforts to increase efficiency and reduce cost in legal and consulting services, commissions and incentives and lower stock-based
compensation, partially offset by an increase in labor costs. Legal and consulting costs decreased by $12.3 million in 2007 due primarily to the absence of costs related to the stock option investigation carried out in 2006. Benefit costs declined
by $4.7 million in 2007 as a result of lower incentives and annual bonuses. Stock-based compensation expense decreased by $9.2 million to $28.5 million in 2007 compared to 2006. During the fourth quarter of 2007, we recorded a $3.5 million
restructuring charge, of which $2.6 million was related to employee severance costs.

"RESEARCH AND DEVELOPMENT EXPENSE" elsewhere:

Nuance Communications (NUAN)
Ultra Clean Holdings (UCTT)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki